"Survival Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
| Descriptor ID |
D016019
|
| MeSH Number(s) |
E05.318.740.998 N05.715.360.750.795 N06.850.520.830.998
|
| Concept/Terms |
Survival Analysis- Survival Analysis
- Analysis, Survival
- Analyses, Survival
- Survival Analyses
|
Below are MeSH descriptors whose meaning is more general than "Survival Analysis".
Below are MeSH descriptors whose meaning is more specific than "Survival Analysis".
This graph shows the total number of publications written about "Survival Analysis" by people in this website by year, and whether "Survival Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 3 | 3 |
| 2002 | 0 | 9 | 9 |
| 2003 | 1 | 11 | 12 |
| 2004 | 0 | 11 | 11 |
| 2005 | 1 | 11 | 12 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 12 | 12 |
| 2008 | 0 | 15 | 15 |
| 2009 | 0 | 14 | 14 |
| 2010 | 0 | 17 | 17 |
| 2011 | 0 | 10 | 10 |
| 2012 | 1 | 11 | 12 |
| 2013 | 0 | 15 | 15 |
| 2014 | 0 | 18 | 18 |
| 2015 | 0 | 20 | 20 |
| 2016 | 0 | 32 | 32 |
| 2017 | 7 | 513 | 520 |
| 2018 | 3 | 506 | 509 |
| 2019 | 3 | 165 | 168 |
| 2020 | 4 | 158 | 162 |
| 2021 | 0 | 68 | 68 |
To return to the timeline, click here.
Below are the most recent publications written about "Survival Analysis" by people in Profiles.
-
Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues. Bioengineered. 2021 12; 12(1):4054-4069.
-
Divergence between serum creatine and cystatin C in estimating glomerular filtration rate of critically ill COVID-19 patients. Ren Fail. 2021 Dec; 43(1):1104-1114.
-
Discontinuation of Continuation or Maintenance Electroconvulsive Therapy Caused by the COVID-19 Pandemic: A Naturalistic Study Investigating Relapse in Patients With Major Depressive Disorder. J ECT. 2021 12 01; 37(4):230-237.
-
Effects of hypertension on the outcomes of COVID-19: a multicentre retrospective cohort study. Ann Med. 2021 12; 53(1):770-776.
-
Clinical and laboratory factors associated with coronavirus disease 2019 (Covid-19): A systematic review and meta-analysis. Rev Med Virol. 2021 11; 31(6):e2288.
-
Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19. Lab Med. 2021 Sep 01; 52(5):493-498.
-
Early days of the pandemic-The association of economic and socio-political country characteristics with the development of the COVID-19 death toll. PLoS One. 2021; 16(8):e0256736.
-
Risk factors associated with mortality in intensive care COVID-19 patients: the importance of chest CT score and intubation timing as risk factors Turk J Med Sci. 2021 08 30; 51(4):1665-1674.
-
India and management of COVID-19: A case study on published guidelines. Drug Discov Ther. 2021 Sep 22; 15(4):171-179.
-
Association between obesity and hospital mortality in critical COVID-19: a retrospective cohort study. Int J Obes (Lond). 2021 12; 45(12):2617-2622.